Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-101940
Filing Date
2016-05-13
Accepted
2016-05-13 17:31:30
Documents
84
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v439235_10q.htm 10-Q 407076
2 EXHIBIT 10.4 v439235_ex10-4.htm EX-10.4 17439
3 EXHIBIT 10.5 v439235_ex10-5.htm EX-10.5 59034
4 EXHIBIT 10.6 v439235_ex10-6.htm EX-10.6 13493
5 EXHIBIT 10.7 v439235_ex10-7.htm EX-10.7 37446
6 EXHIBIT 31.1 v439235_ex31-1.htm EX-31.1 10421
7 EXHIBIT 32.1 v439235_ex32-1.htm EX-32.1 4337
  Complete submission text file 0001144204-16-101940.txt   5763199

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT prgb-20160331.xml EX-101.INS 1243769
9 XBRL TAXONOMY EXTENSION SCHEMA prgb-20160331.xsd EX-101.SCH 66635
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prgb-20160331_cal.xml EX-101.CAL 48226
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prgb-20160331_def.xml EX-101.DEF 419931
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE prgb-20160331_lab.xml EX-101.LAB 463532
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prgb-20160331_pre.xml EX-101.PRE 466545
Mailing Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505
Business Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51474 | Film No.: 161649736
SIC: 2834 Pharmaceutical Preparations